SCHEMBL1630525

SCHEMBL1630525

CCc1ccccc1-n1nccc1-c1cc(I)c(OC)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 3/20 0.44
▸ NR3C2 P08235 1/20 0.39
▸ PDE10A Q9Y233 5/20 0.35
▸ HTR2A P28223 2/20 0.34
▸ HTR2C P28335 2/20 0.34
▸ HRH1 P35367 2/20 0.34
▸ OPRM1 P35372 2/20 0.34
▸ OPRK1 P41145 2/20 0.34
▸ HTR2B P41595 2/20 0.34
▸ HTR6 P50406 2/20 0.34
▸ L3MBTL1 Q9Y468 4/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ KCNN3 Q9UGI6 1/20 0.33
▸ NR1H3 Q13133 1/20 0.33
▸ TSHR P16473 1/20 0.32
▸ KDM5A P29375 1/20 0.32
▸ KDM4C Q9H3R0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1219068 0.85 HSP90AA1 (0.45) HSP90AA1NR3C2PDE10ALMNAALDH1A1
SCHEMBL1629564 0.84 HSP90AA1 (0.44) HSP90AA1NR3C2PDE10AHTR2AHTR2C
SCHEMBL1631531 0.84 HSP90AA1 (0.62) HSP90AA1NR3C2PDE10AHTR2B
SCHEMBL1630306 0.82 ALDH1A1 (0.41) HSP90AA1NR3C2L3MBTL1LMNAHTT
SCHEMBL1629555 0.81 PDE10A (0.48) HSP90AA1PDE10ALMNAALDH1A1MEN1
SCHEMBL1631623 0.80 P2RX7 (0.42) HSP90AA1NR3C2HTR2AHTR2CKDM5A
SCHEMBL1631549 0.79 NPBWR1 (0.41) HSP90AA1PDE10AALDH1A1
SCHEMBL12722868 0.78 AADAT (0.38) HSP90AA1NR3C2PDE10ALMNA
SCHEMBL27743220 0.76 NR3C2 (0.42) HSP90AA1NR3C2PDE10AALDH1A1KDM5A
SCHEMBL27763829 0.75 NR3C2 (0.43) HSP90AA1NR3C2HTR2AHTR2CL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 — — US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885NR3C2 558/4885PDE10A 3756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback